Tardive gait

Clinical Neurology and Neurosurgery

Volumn 110, Issue 2, 2008, Pages 198-201

  Kuo, Sheng Han ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine receptor blocking drugs; Duck like gait; Gait; Tardive dyskinesia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BOTULINUM TOXIN; CARBIDOPA PLUS LEVODOPA; CHLORDIAZEPOXIDE; CLONAZEPAM; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; METOCLOPRAMIDE; NEUROLEPTIC AGENT; PHOSPHATIDYLCHOLINE; PROCHLORPERAZINE; QUETIAPINE; RESERPINE; TETRABENAZINE; TRIFLUOPERAZINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRUXISM; CASE REPORT; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSPHAGIA; FEMALE; GAIT DISORDER; GASTROINTESTINAL DISEASE; HUMAN; INVOLUNTARY MOVEMENT; MALE; MOTOR DYSFUNCTION; PSYCHOSIS; SIDE EFFECT; SPEECH DISORDER; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

AGED; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MIDDLE AGED;

EID: 38349041955     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.09.013     Document Type: Article

References (14)

1. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 18 (1995) 197-214
2. Stacy M., Cardoso F., and Jankovic J. Tardive stereotypy and other movement disorders in tardive dyskinesias. Neurology 43 (1993) 937-941
3. Simpson G.M., and Shrivastava R.K. Abnormal gaits in tardive dyskinesia. Am J Psychiatry 135 (1978) 865
4. Lauterbach E.C., Singh H., Simpson G.M., and Morrison R.L. Gait disorders in tardive dyskinesia. Acta Psychiatr Scand 82 (1990) 267
5. Yassa R. Functional impairment in tardive dyskinesia: medical and psychosocial dimensions. Acta Psychiatr Scand 80 (1989) 64-67
6. Yassa R., and Jones B.D. Complications of tardive dyskinesia: a review. Psychosomatics 26 (1985) 305-313
7. Snijders A.H., van de Warrenburg B.P., Giladi N., and Bloem B.R. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 6 (2007) 63-74
8. Wu L.J., and Jankovic J. Runner's dystonia. J Neurol Sci 251 (2006) 73-76
9. Casey D.E. Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiatry 61 Suppl 4 (2000) 5-9
10. Kulkarni S.K., and Naidu P.S. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives. Drugs Today 39 (2003) 19-49
11. Kenney C., and Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurotherapeut 6 (2006) 7-17
12. Matsumura M. The pedunculopontine tegmental nucleus and experimental parkinsonism. A review. J Neurol Suppl 4 (2005) 5-12
13. van Harten P.N., and Hovestadt A. Botulinum toxin as a treatment for tardive dyskinesia. Mov Disord 21 (2006) 1276-1277
14. Damier P., Thobois S., Witjas T., Cuny E., Derost P., Raoul S., et al. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 64 (2007) 170-176